Dynavax Technologies Corp... (DVAX)
undefined
undefined%
At close: undefined
12.76
-0.12%
After-hours Jan 06, 2025, 04:00 PM EST

Dynavax Technologies Corporation Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2022Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018
H E P L I S A V B Revenue 79.34M 47.84M 150.98M 62.32M 700.00K 82.89M 11.51M 13.28M 263.00K 405.00K -131.00K 417.00K 8.30M 5.63M 3.93M 2.10M 943.00K 86.00K
H E P L I S A V B Revenue Growth +65.84% -68.31% +142.27% +8802.57% -99.16% +619.99% -13.29% +4947.91% -35.06% -409.16% -131.41% -94.98% +47.52% +43.11% +87.42% +122.48% +996.51% n/a
Other Revenue Revenue 1.28M 2.94M 11.79M 7.20M n/a n/a 13.11M n/a 2.40M 10.51M 10.56M 10.16M n/a n/a n/a n/a n/a n/a
Other Revenue Revenue Growth -56.37% -75.03% +63.88% n/a n/a n/a n/a n/a -77.13% -0.42% +3.94% n/a n/a n/a n/a n/a n/a n/a
Product Revenue 79.34M 47.84M 150.98M 62.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue Growth +65.84% -68.31% +142.27% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Non-Us Revenue 1.34M 588.65M 428.00K
Non-Us Revenue Growth -99.77% +137434.81% n/a
United States Revenue 230.94M 8.77M 1.92M
United States Revenue Growth +2532.15% +358.17% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 43.06M 40.80M 42.88M 41.28M 38.05M 37.07M 36.54M 31.02M 32.04M 36.18M 32.17M 29.22M 26.93M 21.58M 22.42M 17.84M 21.54M 18.95M 20.93M 20.32M 18.46M 17.86M 18.35M 16.44M 15.79M 15.65M 16.89M 9.26M 6.03M 5.61M 6.47M 8.17M 11.77M 9.15M 8.17M 6.70M 5.52M 5.10M 4.86M
Selling, General, and Administrative Revenue Growth +5.54% -4.84% +3.87% +8.48% +2.65% +1.44% +17.82% -3.21% -11.43% +12.45% +10.09% +8.53% +24.76% -3.75% +25.70% -17.18% +13.63% -9.42% +2.99% +10.07% +3.35% -2.65% +11.62% +4.12% +0.86% -7.33% +82.49% +53.58% +7.39% -13.29% -20.79% -30.55% +28.58% +12.02% +21.94% +21.27% +8.36% +4.92% n/a
Research and Development Revenue 14.40M 14.95M 13.53M 14.12M 14.12M 13.05M 13.61M 12.85M 12.96M 9.69M 11.10M 11.12M 6.19M 7.17M 7.76M 9.55M 8.52M 5.88M 4.65M 12.27M 12.66M 16.20M 21.21M 22.89M 16.82M 16.27M 18.97M 17.41M 16.42M 14.81M 16.34M 18.44M 23.23M 22.75M 20.07M 20.93M 24.11M 19.69M 22.22M
Research and Development Revenue Growth -3.66% +10.51% -4.19% +0.02% +8.20% -4.11% +5.84% -0.83% +33.78% -12.67% -0.20% +79.71% -13.69% -7.62% -18.76% +12.06% +44.82% +26.46% -62.08% -3.09% -21.83% -23.63% -7.37% +36.10% +3.36% -14.20% +8.92% +6.06% +10.82% -9.37% -11.37% -20.62% +2.13% +13.37% -4.13% -13.16% +22.45% -11.40% n/a